Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect Study of SHC014748M in Healthy Subjects
NCT04006860Phase 1Unknown
- Sponsor
- Nanjing Sanhome Pharmaceutical Co., Ltd.
- Start
- Jul 2019
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of shc014748m in B cell lymphoma, chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) (2 arms), sponsored by Nanjing Sanhome Pharmaceutical Co., Ltd. Primary endpoints: Area Under the Curve from time 0 to the last measurable concentration at 72 hours, Area Under the Curve from time 0 extrapolated to infinity at 72 hours and 1 more. Status: unknown.
02
Drugs
shc014748m
03
Conditions
B cell lymphomachronic lymphocytic leukemia (CLL)small lymphocytic lymphoma (SLL)
Beyond the preview
Go deeper on NCT04006860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04006860.